181 related articles for article (PubMed ID: 5335060)
21. Febuxostat--treatment for hyperuricemia and gout?
Moreland LW
N Engl J Med; 2005 Dec; 353(23):2505-7. PubMed ID: 16339099
[No Abstract] [Full Text] [Related]
22. Biochemical evidence for a distinct type of primary gout.
Sorensen LB; Benke PJ
Nature; 1967 Mar; 213(5081):1122-3. PubMed ID: 6029792
[No Abstract] [Full Text] [Related]
23. [Uric acid inhibitors in the treatment of gout. Apropos of 126 cases].
Serre H; Simon L; Claustre J
Sem Hop; 1970 Dec; 46(50):3295-301. PubMed ID: 4323560
[No Abstract] [Full Text] [Related]
24. Pathogenesis and clinical management of hyperuricemia and gout.
Mangini RJ
J Maine Med Assoc; 1979 Mar; 70(3):118-20, 122-7. PubMed ID: 374661
[No Abstract] [Full Text] [Related]
25. [Allopurinol in the treatment of hyperuricemia and chronic gout].
Benedetti A; Nardini A; Busonera G
Clin Ter; 1968 Apr; 45(2):141-54. PubMed ID: 5736585
[No Abstract] [Full Text] [Related]
26. [Allopurinol].
Scott JT
Schweiz Med Wochenschr; 1967 Dec; 97(49):1659-62. PubMed ID: 5596893
[No Abstract] [Full Text] [Related]
27. Allopurinol in patients with impaired renal function.
Levin NW; Abrahams OL
Ann Rheum Dis; 1966 Nov; 25(6 Suppl):681-7. PubMed ID: 5958698
[No Abstract] [Full Text] [Related]
28. Allopurinol therapy of gout with renal complications.
Sjöberg KH
Ann Rheum Dis; 1966 Nov; 25(6 Suppl):688-90. PubMed ID: 5958699
[No Abstract] [Full Text] [Related]
29. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
[TBL] [Abstract][Full Text] [Related]
30. The management of gout.
Emmerson BT
Med J Aust; 1972 Mar; 1(10):475-8. PubMed ID: 5024419
[No Abstract] [Full Text] [Related]
31. The treatment of gout and disorders of uric acid metabolism with allopurinol.
Ogryzlo MA; Urowitz MB; Weber HM; Houpt JB
Can Med Assoc J; 1966 Nov; 95(22):1120-7. PubMed ID: 5923471
[TBL] [Abstract][Full Text] [Related]
32. Treatment of gout and urate calculi with allopurinol.
O'Duffy JD; Scherbel AL
Cleve Clin Q; 1968 Jul; 35(3):145-54. PubMed ID: 5757545
[No Abstract] [Full Text] [Related]
33. Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout.
Mangini RJ
Am J Hosp Pharm; 1979 Apr; 36(4):497-504. PubMed ID: 433935
[No Abstract] [Full Text] [Related]
34. Gout.
Wyngaarden JB
Adv Metab Disord; 1965; 2():1-78. PubMed ID: 4924371
[No Abstract] [Full Text] [Related]
35. [Current biochemical acquisitions on pathogenesis of gout].
Marcolongo R
Reumatismo; 1971; 23(3):109-25. PubMed ID: 5150688
[No Abstract] [Full Text] [Related]
36. The current state of care in gout: Addressing the need for better understanding of an ancient disease.
Zychowicz ME; Pope RS; Graser E
J Am Acad Nurse Pract; 2010 Nov; 22 Suppl 1():623-36. PubMed ID: 21054636
[TBL] [Abstract][Full Text] [Related]
37. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
[TBL] [Abstract][Full Text] [Related]
38. Metabolic effects of allopurinol and allo-xanthine.
Rundles RW
Ann Rheum Dis; 1966 Nov; 25(6 Suppl):615-20. PubMed ID: 5226510
[No Abstract] [Full Text] [Related]
39. [Allpurinol in the treatment of hyperuricemia and chronic gout].
Benedetti A; Nardini A; Busonera G
Rev Clin Esp; 1969 Mar; 112(6):141-54. PubMed ID: 5347028
[No Abstract] [Full Text] [Related]
40. Hyperuricemia in neoplastic disease in children: prevention with allopurinol, a xanthine oxidase inhibitor.
Krakoff IH; Murphy ML
Pediatrics; 1968 Jan; 41(1):52-6. PubMed ID: 5635486
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
